cyclosporine has been researched along with Adenocarcinoma of Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cikes, M; Hecimovic, A; Jakopovic, M; Jankovic Makek, M; Samarzija, M; Vukic Dugac, A | 1 |
Fukunaga, M; Gon, Y; Hashimoto, S; Mizumura, K; Sato, M; Takahashi, N; Tsujino, I | 1 |
2 other study(ies) available for cyclosporine and Adenocarcinoma of Lung
Article | Year |
---|---|
Treatment of EGFR positive lung adenocarcinoma in a heart transplanted patient.
Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Heart Transplantation; Humans; Immunosuppressive Agents; Lung Neoplasms; Male; Mutation | 2019 |
Cyclosporine A induces apoptosis of human lung adenocarcinoma cells via caspase-dependent pathway.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Blotting, Western; Caspases; Cell Line, Tumor; Cyclosporine; Cytochromes c; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Isoenzymes; Lung Neoplasms; Mitochondria | 2011 |